查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1497654

3D 生物列印市場：按組件、技術和最終用戶分類 - 2024-2030 年全球預測

3D Bioprinting Market by Component (3D Bioprinters, Bioinks), Technology (Extrusion-based Bioprinting, Inkjet-based Bioprinting, Laser-assisted Bioprinting), End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年3D生物列印市場規模為17.9億美元，預計2024年將達21.4億美元，2030年將達到63.9億美元，複合年成長率為19.89%。

3D 生物列印是一種將生物墨水與活細胞融合以創建類似組織的 3D 結構的技術。該過程在3D空間中逐層列印生物墨水和細胞的混合物。近年來，對3D生物列印技術的需求顯著成長，並已成為各種生物醫學應用的重要工具。疾病建模和組織工程是這項創新技術產生重大影響的兩個重要領域。全球慢性病數量迅速增加，以及對有效治療的需求不斷成長，正在推動對 3D 生物列印徹底改變醫療保健潛力的研究。此外，對個人化醫療應用的需求不斷成長，需要根據個人需求量身定製配方和治療方法，而 3D 生物列印在實現基於患者遺傳特徵和疾病特徵的客製化方面發揮關鍵作用。可擴展性是 3D 生物列印的關鍵問題。創造更大、更複雜的組織和器官需要提高列印過程的速度和精確度。然而，近年來，專注於開發用於 3D 生物列印應用的新型生醫材料的研究顯著增加。由天然和合成聚合物組成的新型生物墨水專為 3D 生物列印而設計。與傳統材料相比，這些生醫材料具有多種優勢，包括提高的生物相容性、可調節的機械性能和改善的細胞黏附性能，這些性能對於組織再生至關重要。

主要市場統計
基準年[2023] 17.9億美元
預測年份 [2024] 21.4億美元
預測年份 [2030] 63.9億美元
複合年成長率（%） 19.89%

區域洞察

由於技術進步、成熟的製藥業和強大的研究基礎設施，美洲 3D 生物列印市場正在不斷成長。美國在美國地區佔有重要地位，擁有大量聯邦資金支持3D生物列印研發計劃。此外，北美的一些學術機構還建立了專用3D生物列印的研究設施。歐洲正在經歷慢性病的增加和人口老化，迫切需要更有效的藥物和個人化治療，並推動 3D 生物列印等生物技術的進步。在歐洲，德國、英國、法國和瑞典等國家已成為製藥領域採用3D生物列印技術的重要參與者。近年來，亞洲已成為器官移植的中心，隨著該地區人口的成長、預期壽命的延長以及慢性病和需要器官移植的疾病的數量相應增加，3D生物列印技術的進步正在迅速加速。此外，亞洲國家之間在醫學研究和技術方面區域合作的發展也對這一成長做出了重大貢獻。印度和中國在開發新穎解決方案方面擁有強大的立足點，並專注於 3D 生物列印技術，例如使用積層製造製程的生物人工器官。

FPNV定位矩陣

FPNV定位矩陣對於評估供應商在3D生物列印市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對 3D 生物列印市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在 3D 生物列印市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對疾病模型和組織工程的需求不斷成長
      • 藥物和錠劑研究中擴大採用 3D 生物列印
    • 抑制因素
      • 對合適印刷材料的擴充性和可用性的擔憂
    • 機會
      • 增加為博士學術計劃提供的研究經費
      • 3D 生物列印機和生醫材料的爆炸性進步
    • 任務
      • 細胞生物學研究需要大量資金
  • 市場區隔分析
    • 組成部分：擴大可適應各種應用的 3D 生物列印機的使用
    • 最終用戶：製藥和生物技術公司的 3D 生物列印使用量激增
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第 6 章 3D 生物列印市場：按組成部分

  • 3D生物列印機
  • 生物墨水

第 7 章 3D 生物列印市場：依技術分類

  • 擠壓法生物列印
  • 基於噴墨的生物列印
  • 雷射輔助生物列印

第 8 章 3D 生物列印市場：依最終用戶分類

  • 製藥和生物技術公司
  • 調查機構

第9章美洲3D生物列印市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太3D生物列印市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的3D生物列印市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Readyly3D推出先進的生物墨水，可精確列印複雜組織
    • BIO INX 與 Rousselot 合作推進 3D 生物列印材料
    • Nexa3D 透過收購 Essentium 擴大市場規模
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-43649B5EE3C4

[189 Pages Report] The 3D Bioprinting Market size was estimated at USD 1.79 billion in 2023 and expected to reach USD 2.14 billion in 2024, at a CAGR 19.89% to reach USD 6.39 billion by 2030.

3D bioprinting is technology that merges bioinks and living cells to fabricate 3D structures resembling tissues. This process entails printing the bioink and cell mixture layer by layer in a three-dimensional space. In recent years, the demand for 3D bioprinting technologies has experienced significant growth, emerging as a vital tool in various biomedical applications. Disease modeling and tissue engineering are two critical areas in which this innovative technology is making a substantial impact. The burgeoning prevalence of chronic diseases globally and an increasing need for effective treatments have spurred researchers to explore the potential of 3D bioprinting in revolutionizing healthcare. Additionally, there has been a rising demand for personalized medicine applications that necessitate patient-specific drug formulations and treatments tailored to individual needs, where 3D bioprinting plays an essential role by allowing for customization based on patients' genetic profiles or disease characteristics. Scalability remains a significant challenge for 3D bioprinting as current technologies primarily focus on producing smaller tissue constructs. Creating larger and more complex tissues and organs requires advancements in both the speed and precision of printing processes. However, there has been a marked increase in research focused on developing novel biomaterials for 3D bioprinting applications in recent years. New bioinks composed of natural and synthetic polymers are explicitly designed for 3D bioprinting. These biomaterials offer several advantages over conventional materials, including enhanced biocompatibility, tunable mechanical properties, and improved cell adhesion characteristics, essentially required for tissue regeneration.

KEY MARKET STATISTICS
Base Year [2023] USD 1.79 billion
Estimated Year [2024] USD 2.14 billion
Forecast Year [2030] USD 6.39 billion
CAGR (%) 19.89%

Regional Insights

The Americas 3D bioprinting market is growing due to technological advancement, a well-established pharmaceutical industry, and a robust research infrastructure. The United States witnessed a significant position in the American region with notable federal funding to support R&D projects in 3D bioprinting. Furthermore, several North American academic institutions have established dedicated 3D bioprinting research facilities. Europe has been witnessing an increasing prevalence of chronic diseases and an expanding geriatric population, creating an urgent need for more effective pharmaceutical drugs and personalized treatments, which has boosted the advancements in biotechnology, such as 3D bioprinting. Across Europe, countries such as Germany, the UK, France, and Sweden have emerged as critical players in adopting 3D bioprinting technologies within their pharmaceutical sectors. In recent years, Asia has emerged as a rising hub for organ transplantation, and 3D bioprinting advancements surged majorly due to the region's growing population, its increasing life expectancy, and the subsequent rise in chronic diseases and ailments requiring organ transplants. Furthermore, the development of regional collaboration among Asian countries in medical research and technology has significantly contributed to this growth. India and China have established a strong foothold in developing novel solutions and have specialized in 3D bioprinting technologies such as bioartificial organs using additive manufacturing processes.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the 3D Bioprinting Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising demand for disease modeling and tissue engineering
      • Increase in deployment of 3D bioprinting across research of drugs and pills
    • Market Restraints
      • Concern over scalability and availability of suitable printing materials
    • Market Opportunities
      • Increasing research funding provided to doctoral academic projects
      • Proliferation in advancements of 3D bioprinters and biomaterials
    • Market Challenges
      • Capital intensive to perform cell biology research
  • Market Segmentation Analysis
    • Component: Proliferating utilization of the 3D bioprinters capable of adapting to a range of applications
    • End-user: Burgeoning usage of the 3D bioprinting across the pharmaceutical & biotechnology companies
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the 3D Bioprinting Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the 3D Bioprinting Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Readily3D Unveils Advanced Bio-Inks for Precision 3D Bioprinting of Complex Tissues

Readily3D, a Swiss company specializing in 3D printing technologies, has announced the development of next-generation bio-inks for use in medical applications. This innovative product aims to enhance organ and tissue modeling by addressing the demand for high precision and compatibility in 3D bioprinting. By optimizing the viscosity of these bio-inks, Readily3D ensures smoother functioning in printing mechanisms, which is crucial for creating complex tissues such as those found in the human pancreas. This advancement promises to drive forward the capabilities in medical research and transplantation. It aligns with broader efforts in the industry to tailor bioprinting materials for specific medical needs, potentially revolutionizing patient-specific treatments. [Published On: 2024-05-23]

BIO INX Partners with Rousselot for Advancements in 3D Bioprinting Materials

BIO INX has partnered with Rousselot, a player in gelatin production, to elevate the field of 3D bioprinting. This partnership aims to leverage Rousselot's extensive expertise in gelatin formulation to revolutionize the development of high-quality bio inks. Such innovative bioinks are crucial for advancing 3D bioprinting technologies, which are pivotal in generating complex biological structures that can potentially lead to medical research and treatment breakthroughs. This partnership is set to combine BIO INX's cutting-edge bioprinting techniques with Rousselot's long-standing excellence in gelatin expertise, setting a promising path toward significant enhancements in the quality and performance of 3D printed products. [Published On: 2024-03-12]

Nexa3D Expands Market Footprint with the Acquisition of Essentium

Nexa3D, a player in ultra-fast stereolithography 3D printers, announced the acquisition of Essentium to broaden its capabilities and market reach in the high-speed extrusion (HSE) 3D printing sector. This transaction marks a significant step for Nexa3D in expanding its high-speed polymer 3D printers and materials portfolio. Essentium is renowned for its groundbreaking HSE 3D printing platform, which complements Nexa3D's existing product offerings and is expected to enhance its operational scale and innovation capacity in serving a growing global customer base. This acquisition aligns with Nexa3D's strategy to lead the additive manufacturing industry by integrating and optimizing production workflows and democratizing access to scalable additive manufacturing solutions. [Published On: 2024-01-12]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the 3D Bioprinting Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the 3D Bioprinting Market, highlighting leading vendors and their innovative profiles. These include 3D BioFibR, 3D Bioprinting Solutions, 3D Systems Corporation, Advanced Solutions, Inc., Aspect Biosystems Ltd., Avay Biosciences Private Limited, Axiom Space, Inc., Axolotl Biosystems Ltd., BICO Group AB, Brinter Inc., Cellbricks GmbH, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal, Inc., Fluicell AB, FluidForm, Inc., FUJIFILM Corporation, GE HealthCare Technologies Inc., GeSiM, Inventia Life Science Pty Ltd., Medprin Regenerative Medical Technologies Co., Ltd., Merck KGaA, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Precise Bio Inc., Prellis Biologics, PrintBio, Inc, REGEMAT 3D S.L., regenHU Ltd., Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd., ROKIT Healthcare Inc., TheWell Bioscience Inc., UPM-Kymmene Corporation, and UpNano GmbH.

Market Segmentation & Coverage

This research report categorizes the 3D Bioprinting Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • 3D Bioprinters
    • Bioinks
  • Technology
    • Extrusion-based Bioprinting
    • Inkjet-based Bioprinting
    • Laser-assisted Bioprinting
  • End-user
    • Pharmaceutical & Biotechnology Companies
    • Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for disease modeling and tissue engineering
      • 5.1.1.2. Increase in deployment of 3D bioprinting across research of drugs and pills
    • 5.1.2. Restraints
      • 5.1.2.1. Concern over scalability and availability of suitable printing materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing research funding provided to doctoral academic projects
      • 5.1.3.2. Proliferation in advancements of 3D bioprinters and biomaterials
    • 5.1.4. Challenges
      • 5.1.4.1. Capital intensive to perform cell biology research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Proliferating utilization of the 3D bioprinters capable of adapting to a range of applications
    • 5.2.2. End-user: Burgeoning usage of the 3D bioprinting across the pharmaceutical & biotechnology companies
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. 3D Bioprinting Market, by Component

  • 6.1. Introduction
  • 6.2. 3D Bioprinters
  • 6.3. Bioinks

7. 3D Bioprinting Market, by Technology

  • 7.1. Introduction
  • 7.2. Extrusion-based Bioprinting
  • 7.3. Inkjet-based Bioprinting
  • 7.4. Laser-assisted Bioprinting

8. 3D Bioprinting Market, by End-user

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research Organizations

9. Americas 3D Bioprinting Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific 3D Bioprinting Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa 3D Bioprinting Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Readily3D Unveils Advanced Bio-Inks for Precision 3D Bioprinting of Complex Tissues
    • 12.3.2. BIO INX Partners with Rousselot for Advancements in 3D Bioprinting Materials
    • 12.3.3. Nexa3D Expands Market Footprint with the Acquisition of Essentium
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. 3D BIOPRINTING MARKET RESEARCH PROCESS
  • FIGURE 2. 3D BIOPRINTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL 3D BIOPRINTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. 3D BIOPRINTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. 3D BIOPRINTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL 3D BIOPRINTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL 3D BIOPRINTING MARKET SIZE, BY 3D BIOPRINTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL 3D BIOPRINTING MARKET SIZE, BY 3D BIOPRINTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL 3D BIOPRINTING MARKET SIZE, BY BIOINKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL 3D BIOPRINTING MARKET SIZE, BY BIOINKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL 3D BIOPRINTING MARKET SIZE, BY EXTRUSION-BASED BIOPRINTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL 3D BIOPRINTING MARKET SIZE, BY EXTRUSION-BASED BIOPRINTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL 3D BIOPRINTING MARKET SIZE, BY INKJET-BASED BIOPRINTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL 3D BIOPRINTING MARKET SIZE, BY INKJET-BASED BIOPRINTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL 3D BIOPRINTING MARKET SIZE, BY LASER-ASSISTED BIOPRINTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL 3D BIOPRINTING MARKET SIZE, BY LASER-ASSISTED BIOPRINTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL 3D BIOPRINTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL 3D BIOPRINTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL 3D BIOPRINTING MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL 3D BIOPRINTING MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023